- First subject received unilateral administration of NRTX-1001 in a new non-MTS cohort; no significant surgical complications or adverse events reported to date - - Data from this non-MTS cohort, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback